Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing Checkpoint Inhibitor Therapy

被引：1

作者：

Shah, Pavan P. ^{[1
]}

Romo, Carlos G. ^{[2
]}

Yarchoan, Mark ^{[3
]}

机构：

[1] Johns Hopkins Sch Med, Baltimore, MD USA

[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

[3] Johns Hopkins Univ, Baltimore, MD 21218 USA

来源：

JAMA ONCOLOGY | 2019年 / 5卷 / 10期

关键词：

MYASTHENIA-GRAVIS;

D O I：

10.1001/jamaoncol.2019.2304

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1497 / 1498

页数：2

共 10 条

[1] Miller Fisher Syndrome Associated With Immunotherapy for Metastatic Melanoma [J].

Baird-Gunning, Onathan J. D. ;

Weerasinghe, Dinushi ;

Silsby, Matthew ;

Gawarikar, Yash ;

Carlino, Matteo S. ;

Smith, Jessica L. ;

Vucic, Steve .

NEUROHOSPITALIST, 2018, 8 (04) :191-193

[2]

Cuzzubbo S, 2017, EUR J CANCER, V73, P1, DOI [10.1016/j.ejca.2016.12:001, 10.1016/j.ejca.2016.12.001]

[3] Neurological complications of immune checkpoint inhibitors: what happens when you "take the brakes off' the immune system [J].

Dalakas, Marinos C. .

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11

[4] Early B cell changes predict autoimmunity following combination immune checkpoint blockade [J].

Das, Rituparna ;

Bar, Noffar ;

Ferreira, Michelle ;

Newman, Aaron M. ;

Zhang, Lin ;

Bailur, Jithendra Kini ;

Bacchiocchi, Antonella ;

Kluger, Harriet ;

Wei, Wei ;

Halaban, Ruth ;

Sznol, Mario ;

Dhodapkar, Madhav V. ;

Dhodapkar, Kavita M. .

JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02) :715-720

[5] Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].

Hoch, W ;

McConville, J ;

Helms, S ;

Newsom-Davis, J ;

Melms, A ;

Vincent, A .

NATURE MEDICINE, 2001, 7 (03) :365-368

[6] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors [J].

Kao, Justin C. ;

Brickshawana, Adipong ;

Liewluck, Teerin .

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)

[7] Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors [J].

Makarious, D. ;

Horwood, K. ;

Coward, J. I. G. .

EUROPEAN JOURNAL OF CANCER, 2017, 82 :128-136

[8] Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer [J].

Nakatani, Yuki ;

Tanaka, Natsuki ;

Enami, Tomomi ;

Minami, Seigo ;

Okazaki, Tomoko ;

Komuta, Kiyoshi .

CASE REPORTS IN NEUROLOGY, 2018, 10 (03) :346-352

[9] Reliability of SFEMG in diagnosing myasthenia gravis: Sensitivity and specificity calculated on 100 prospective cases [J].

Padua, L. ;

Caliandro, P. ;

Di Iasi, G. ;

Pazzaglia, C. ;

Ciaraffa, F. ;

Evoli, A. .

CLINICAL NEUROPHYSIOLOGY, 2014, 125 (06) :1270-1273

[10]

Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMc1801663, 10.1056/NEJMra1703481]

← 1 →